The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on div

Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a two-drug obesity combo, and t

The US FDA has approved Eli Lilly's drug combination to treat adults with a type of advanced breast

Inluriyo plus Verzenio delivers proven clinical benefit after the evidence-based practice of maximiz

Inluriyo plus Verzenio delivers proven clinical benefit after the evidence-based practice of maximiz

William Blair initiates Perspective Therapeutics (NYSE: CATX) at Outperform, citing its strong radio

Eli Lilly has generated explosive growth thanks to its weight loss drug portfolio. Costco's focus on

Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and raises the pric

Novo Nordisk wins CHMP recommendation for hemophilia drug FREHEMGO and enters a $1.4 billion cardiom

Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsFed raise

Eli Lilly dominates the weight loss drug market -- one set to approach $100 billion in a few years.

It's impossible to take all the risk out of investing. But that doesn't mean investors can't make a

There is a correlation between increasing dividends and strong investment performance — even if a st

Twist Bioscience Corporation (NASDAQ:TWST) on Wednesday announced an agreement with Lilly TuneLab, a

Twist Bioscience joins Eli Lilly's TuneLab platform, supplying high-throughput antibody data to

Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the f

Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsFed poise

PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper dr

When it comes to investing, there is no one-size-fits-all approach. Strategies vary based on numerou

Eli Lilly's breakthroughs in its core therapeutic area are driving excellent financial results. The

Berenberg upgraded Eli Lilly (LLY) to buy from hold and boosted its price target to $1,400 from $1,2

Shares of Eli Lilly and Company (NYSE:LLY) are trading higher Tuesday morning following positive pre

Shares of Eli Lilly and Company are trading higher Tuesday following positive previews of its late-s

Eli Lilly's bulls are pointing at a 47% revenue surge and a pipeline loaded with blockbuster candida

Eli Lilly and Merck both reported second quarter earnings, and the contrast could not be sharper. On

Markets are rattled ahead of Wednesday's Fed decision, and Wall Street analysts are making bold move

 Eli Lilly and Company (NYSE:LLY), the maker of Zepbound (tirzepatide), Mounjaro (tirzepatide) and F

Eli Lilly (LLY) concluded the recent trading session at $1, signifying a +1.99% move from its prior

Eli Lilly and Company (LLY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran

Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral o

Eli Lilly and Company NYSE: LLY is pursuing a broad obesity portfolio designed to address different

Eli Lilly shed billions in market value over the past month while its underlying business kept break

Novo Nordisk rebrands as 'Novo' as it seeks to regain obesity drug market share and unveils

As bootleg versions of an experimental drug from Eli Lilly flood the market, regulators are trying t

Novartis recently announced bad news for its Lp(a)-lowering drug, pelacarsen. Lilly is also developi

Novo Nordisk launched its Wegovy pill in early 2026, with Eli Lilly quickly following with a pill ca

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Read this week's top deal updates, including Bending Spoons' Miro deal, Chime's Stride B

Eli Lilly is expanding into women's health, targeting endometriosis and pregnancy disorders by h

President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Mor

HSBC analyst Rajesh Kumar maintains Eli Lilly (NYSE:LLY) with a Reduce and raises the price targe

Kura Oncology launches Caspian Therapeutics with $50 million financing to advance menin inhibitor fo

Eli Lilly (NYSE:LLY) has outperformed the market over the past 10 years by 16.85% on an annualized b

JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could bene

Eli Lilly (LLY) falls 2% amid a broader healthcare sell-off. Key support levels, technical breakdown

Major M&A deals include Flex buys EPC Power for $4.4 Billion, KKR acquires A1 Garage Door, Starm

FDA warns of risks from unapproved compounded GLP-1 drugs including semaglutide and tirzepatide amid

Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from

As previously disclosed, AtaiBeckley Inc. (the "Company") entered into an Agreement and Plan